Movatterモバイル変換


[0]ホーム

URL:


SG11201704660YA - Use of markers including filamin a in the diagnosis and treatment of prostate cancer - Google Patents

Use of markers including filamin a in the diagnosis and treatment of prostate cancer

Info

Publication number
SG11201704660YA
SG11201704660YASG11201704660YASG11201704660YASG11201704660YASG 11201704660Y ASG11201704660Y ASG 11201704660YASG 11201704660Y ASG11201704660Y ASG 11201704660YASG 11201704660Y ASG11201704660Y ASG 11201704660YASG 11201704660Y ASG11201704660Y ASG 11201704660YA
Authority
SG
Singapore
Prior art keywords
diagnosis
treatment
prostate cancer
markers including
filamin
Prior art date
Application number
SG11201704660YA
Inventor
Niven Rajin Narain
Vivek K Vishnudas
Rangaprasad Sarangarajan
Viatcheslav R Akmaev
Original Assignee
Berg Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berg LlcfiledCriticalBerg Llc
Publication of SG11201704660YApublicationCriticalpatent/SG11201704660YA/en

Links

Classifications

Landscapes

SG11201704660YA2014-12-082015-12-08Use of markers including filamin a in the diagnosis and treatment of prostate cancerSG11201704660YA (en)

Applications Claiming Priority (4)

Application NumberPriority DateFiling DateTitle
US201462088931P2014-12-082014-12-08
US201562134956P2015-03-182015-03-18
US201562148294P2015-04-162015-04-16
PCT/US2015/064530WO2016094425A1 (en)2014-12-082015-12-08Use of markers including filamin a in the diagnosis and treatment of prostate cancer

Publications (1)

Publication NumberPublication Date
SG11201704660YAtrue SG11201704660YA (en)2017-07-28

Family

ID=56108067

Family Applications (2)

Application NumberTitlePriority DateFiling Date
SG10202012249YASG10202012249YA (en)2014-12-082015-12-08Use of markers including filamin a in the diagnosis and treatment of prostate cancer
SG11201704660YASG11201704660YA (en)2014-12-082015-12-08Use of markers including filamin a in the diagnosis and treatment of prostate cancer

Family Applications Before (1)

Application NumberTitlePriority DateFiling Date
SG10202012249YASG10202012249YA (en)2014-12-082015-12-08Use of markers including filamin a in the diagnosis and treatment of prostate cancer

Country Status (10)

CountryLink
US (3)US10539566B2 (en)
EP (2)EP4242329A3 (en)
JP (1)JP6759229B2 (en)
KR (1)KR102657306B1 (en)
CN (1)CN107428821B (en)
AU (1)AU2015360694B2 (en)
CA (1)CA2970143A1 (en)
IL (1)IL252766B (en)
SG (2)SG10202012249YA (en)
WO (1)WO2016094425A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US10217619B2 (en)*2015-03-122019-02-26Thermo Finnigan LlcMethods for data-dependent mass spectrometry of mixed intact protein analytes
EP3281151B1 (en)*2015-04-102023-03-29President and Fellows of Harvard CollegeMethods and devices for live cell imaging analysis
US20180024132A1 (en)*2016-07-072018-01-25Berg LlcLipid, protein, and metabolite markers for the diagnosis and treatment of prostate cancer
US11360092B2 (en)2016-08-052022-06-14The Research Foundation For The State University Of New YorkKeratin 17 as a biomarker for bladder cancer
WO2018085431A1 (en)*2016-11-012018-05-11Berg LlcFilamin a binding proteins and uses thereof
WO2018085441A1 (en)*2016-11-012018-05-11Berg LlcFilamin b binding proteins and uses thereof
WO2018189292A1 (en)*2017-04-132018-10-18Institut National De La Sante Et De La Recherche MedicaleBiomarkers of castration-resistant prostatic cells
WO2019067092A1 (en)2017-08-072019-04-04The Johns Hopkins UniversityMethods and materials for assessing and treating cancer
WO2019226347A1 (en)2018-05-242019-11-28Sigma-Aldrich Co. LlcQuantitative analysis of proteins
CN108624691A (en)*2018-06-222018-10-09杭州西合精准医疗科技有限公司A kind of marker and its application for judging prostatic disorders
MA53141A (en)*2018-07-122021-05-19Berg Llc PROCESSES FOR DIFFERENTIATING PROSTATIC HYPERPLASIA UNDER PROSTATE CANCER
AU2019358060A1 (en)2018-10-092021-04-29Ibex Biosciences, Inc.Antibodies directed to filamin-A and therapeutic uses thereof
US20210080466A1 (en)*2019-06-262021-03-18Berg LlcMarkers for the diagnosis of prostate cancer
US11042980B1 (en)*2020-01-022021-06-22Robert Edwin DouglasMethod and apparatus for using quantative and qualitative data from medical imaging examinations for precise dosing regimen
CN114134223B (en)*2021-12-022022-10-11青岛市中心血站Blood detection kit for hepatitis C virus-related liver fibrosis
CN114155956B (en)*2021-12-022022-09-20首都医科大学附属北京地坛医院System and method for predicting blood vessel invasion probability of primary liver cancer patient incapable of being resected by surgery
CN114460297A (en)*2022-01-172022-05-10珠海中科先进技术研究院有限公司 An immunofluorescence kit for detecting circulating prostate epithelial cells in blood and method of using the same
CN114882996B (en)*2022-03-172023-04-07深圳大学Hepatocellular carcinoma CK19 and MVI prediction method based on multitask learning
CN117843753A (en)*2022-10-042024-04-09中国医学科学院药物研究所 Keratin YK93-2, preparation method, pharmaceutical composition and use thereof
DE102023125869A1 (en)*2023-09-252025-03-27Numares Ag Use of a marker set to differentiate between prostate cancer and benign prostatic changes
CN118497334B (en)*2024-06-052025-08-01武汉大学中南医院Application of substance for inhibiting FLNC gene expression in preparation of medicine for treating benign prostatic hyperplasia

Family Cites Families (197)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
NL154598B (en)1970-11-101977-09-15Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING.
US3817837A (en)1971-05-141974-06-18Syva CorpEnzyme amplification assay
US3939350A (en)1974-04-291976-02-17Board Of Trustees Of The Leland Stanford Junior UniversityFluorescent immunoassay employing total reflection for activation
US3996345A (en)1974-08-121976-12-07Syva CompanyFluorescence quenching with immunological pairs in immunoassays
US4196265A (en)1977-06-151980-04-01The Wistar InstituteMethod of producing antibodies
US4277437A (en)1978-04-051981-07-07Syva CompanyKit for carrying out chemically induced fluorescence immunoassay
US4275149A (en)1978-11-241981-06-23Syva CompanyMacromolecular environment control in specific receptor assays
US4366241A (en)1980-08-071982-12-28Syva CompanyConcentrating zone method in heterogeneous immunoassays
US4816567A (en)1983-04-081989-03-28Genentech, Inc.Recombinant immunoglobin preparations
US4786600A (en)1984-05-251988-11-22The Trustees Of Columbia University In The City Of New YorkAutocatalytic replication of recombinant RNA
US4883750A (en)1984-12-131989-11-28Applied Biosystems, Inc.Detection of specific sequences in nucleic acids
US4683202A (en)1985-03-281987-07-28Cetus CorporationProcess for amplifying nucleic acid sequences
US4683195A (en)1986-01-301987-07-28Cetus CorporationProcess for amplifying, detecting, and/or-cloning nucleic acid sequences
US6040166A (en)1985-03-282000-03-21Roche Molecular Systems, Inc.Kits for amplifying and detecting nucleic acid sequences, including a probe
US4800159A (en)1986-02-071989-01-24Cetus CorporationProcess for amplifying, detecting, and/or cloning nucleic acid sequences
AU622104B2 (en)1987-03-111992-04-02Sangtec Molecular Diagnostics AbMethod of assaying of nucleic acids, a reagent combination and kit therefore
IL86724A (en)1987-06-191995-01-24Siska Diagnostics IncMethod and kits for the amplification and detection of nucleic acid sequences
US5585481A (en)1987-09-211996-12-17Gen-Probe IncorporatedLinking reagents for nucleotide probes
CA1323293C (en)1987-12-111993-10-19Keith C. BackmanAssay using template-dependent nucleic acid probe reorganization
WO1989006700A1 (en)1988-01-211989-07-27Genentech, Inc.Amplification and detection of nucleic acid sequences
CA1340807C (en)1988-02-241999-11-02Lawrence T. MalekNucleic acid amplification process
US5700637A (en)1988-05-031997-12-23Isis Innovation LimitedApparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5223409A (en)1988-09-021993-06-29Protein Engineering Corp.Directed evolution of novel binding proteins
GB8822228D0 (en)1988-09-211988-10-26Southern E MSupport-bound oligonucleotides
US4932207A (en)1988-12-281990-06-12Sundstrand CorporationSegmented seal plate for a turbine engine
US6040138A (en)1995-09-152000-03-21Affymetrix, Inc.Expression monitoring by hybridization to high density oligonucleotide arrays
US5242974A (en)1991-11-221993-09-07Affymax Technologies N.V.Polymer reversal on solid surfaces
US5424186A (en)1989-06-071995-06-13Affymax Technologies N.V.Very large scale immobilized polymer synthesis
US5143854A (en)1989-06-071992-09-01Affymax Technologies N.V.Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5527681A (en)1989-06-071996-06-18Affymax Technologies N.V.Immobilized molecular synthesis of systematically substituted compounds
DE3924454A1 (en)1989-07-241991-02-07Cornelis P Prof Dr Hollenberg THE APPLICATION OF DNA AND DNA TECHNOLOGY FOR THE CONSTRUCTION OF NETWORKS FOR USE IN CHIP CONSTRUCTION AND CHIP PRODUCTION (DNA CHIPS)
DE3938907C2 (en)1989-11-241999-11-04Dade Behring Marburg Gmbh Means for storing and suspending cells, in particular erythrocytes
DE3942999C2 (en)1989-12-271997-12-18Progen Biotechnik Gmbh Procedure for the detection of malignant diseases
IL103674A0 (en)1991-11-191993-04-04Houston Advanced Res CenterMethod and apparatus for molecule detection
US5384261A (en)1991-11-221995-01-24Affymax Technologies N.V.Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5412087A (en)1992-04-241995-05-02Affymax Technologies N.V.Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
ES2227512T3 (en)1991-12-022005-04-01Medical Research Council PRODUCTION OF ANTIBODIES AGAINST SELF-ANTIGENS FROM REPERTORIES OF ANTIBODY SEGMENTS FIXED IN A PHOTO.
AU669353B2 (en)1991-12-241996-06-06Isis Pharmaceuticals, Inc.Gapped 2' modified oligonucleotides
DE4208422A1 (en)1992-03-161993-09-30Boehringer Mannheim Gmbh Method for the detection of micrometastases of ectodermal or endodermal tumors
EP0672187A4 (en)1992-10-081999-11-17Univ California PCR ASSAYS FOR DETERMINING THE PRESENCE AND CONCENTRATION OF A TARGET.
US5554501A (en)1992-10-291996-09-10Beckman Instruments, Inc.Biopolymer synthesis using surface activated biaxially oriented polypropylene
US5422252A (en)1993-06-041995-06-06Becton, Dickinson And CompanySimultaneous amplification of multiple targets
US5837832A (en)1993-06-251998-11-17Affymetrix, Inc.Arrays of nucleic acid probes on biological chips
JP3954092B2 (en)1993-06-252007-08-08アフィメトリックス インコーポレイテッド Nucleic acid sequence hybridization and sequencing
US5472672A (en)1993-10-221995-12-05The Board Of Trustees Of The Leland Stanford Junior UniversityApparatus and method for polymer synthesis using arrays
US6045996A (en)1993-10-262000-04-04Affymetrix, Inc.Hybridization assays on oligonucleotide arrays
US5429807A (en)1993-10-281995-07-04Beckman Instruments, Inc.Method and apparatus for creating biopolymer arrays on a solid support surface
US5538848A (en)1994-11-161996-07-23Applied Biosystems Division, Perkin-Elmer Corp.Method for detecting nucleic acid amplification using self-quenching fluorescence probe
CA2185239C (en)1994-03-162002-12-17Nanibhushan DattaguptaIsothermal strand displacement nucleic acid amplification
EP0760008A1 (en)1994-05-191997-03-05Dako A/SPna probes for detection of neisseria gonorrhoeae and chlamydia trachomatis
US5571639A (en)1994-05-241996-11-05Affymax Technologies N.V.Computer-aided engineering system for design of sequence arrays and lithographic masks
US5807522A (en)1994-06-171998-09-15The Board Of Trustees Of The Leland Stanford Junior UniversityMethods for fabricating microarrays of biological samples
US5556752A (en)1994-10-241996-09-17Affymetrix, Inc.Surface-bound, unimolecular, double-stranded DNA
US5599695A (en)1995-02-271997-02-04Affymetrix, Inc.Printing molecular library arrays using deprotection agents solely in the vapor phase
US5624711A (en)1995-04-271997-04-29Affymax Technologies, N.V.Derivatization of solid supports and methods for oligomer synthesis
US5545531A (en)1995-06-071996-08-13Affymax Technologies N.V.Methods for making a device for concurrently processing multiple biological chip assays
JP4436457B2 (en)1995-08-182010-03-24モルフォシス アイピー ゲーエムベーハー Protein / (poly) peptide library
US5658734A (en)1995-10-171997-08-19International Business Machines CorporationProcess for synthesizing chemical compounds
DK0938320T3 (en)1996-03-262010-10-18Michael S Kopreski Method of extracting extracellular RNA from plasma or serum to detect, monitor or assess cancer
US5898031A (en)1996-06-061999-04-27Isis Pharmaceuticals, Inc.Oligoribonucleotides for cleaving RNA
DE69736667T2 (en)1996-07-162007-09-06Gen-Probe Inc., San Diego PROCESS FOR THE DETECTION AND AMPLIFICATION OF NUCLEIC ACID SEQUENCES USING MODIFIED OLIGONUCLEOTIDES WITH INCREASED TARGET MELT TEMPERATURE (TM)
WO1999014372A1 (en)1997-09-151999-03-25Abbott LaboratoriesReagents and methods useful for detecting diseases of the urinary tract
US7361336B1 (en)1997-09-182008-04-22Ivan BergsteinMethods of cancer therapy targeted against a cancer stem line
US6130101A (en)1997-09-232000-10-10Molecular Probes, Inc.Sulfonated xanthene derivatives
US6124120A (en)1997-10-082000-09-26Yale UniversityMultiple displacement amplification
US6218114B1 (en)1998-03-272001-04-17Academia SinicaMethods for detecting differentially expressed genes
US6004755A (en)1998-04-071999-12-21Incyte Pharmaceuticals, Inc.Quantitative microarray hybridizaton assays
US6218122B1 (en)1998-06-192001-04-17Rosetta Inpharmatics, Inc.Methods of monitoring disease states and therapies using gene expression profiles
AU1449500A (en)1998-10-222000-05-08Curagen CorporationGenes and proteins predictive and therapeutic for renal disease and associated disorders
CA2359816C (en)1999-01-062010-08-03Genenews Inc.Method for the detection of gene transcripts in blood and uses thereof
US7368527B2 (en)1999-03-122008-05-06Human Genome Sciences, Inc.HADDE71 polypeptides
US8410248B2 (en)1999-03-122013-04-02Human Genome Sciences Inc.HWBAO62 polypeptides
US6271002B1 (en)1999-10-042001-08-07Rosetta Inpharmatics, Inc.RNA amplification method
US6607885B1 (en)1999-10-152003-08-19E. I. Du Pont De Nemours And CompanyMethod for high-density microarray medicated gene expression profiling
US6448086B1 (en)2000-01-182002-09-10Diagnostic Systems Laboratories, Inc.Insulin-like growth factor system and cancer
ATE469242T1 (en)2000-03-272010-06-15Univ Jefferson COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS FROM THE DIGESTIVE CANAL
AU2001285047A1 (en)2000-08-162002-02-25Chiron CorporationHuman genes and gene expression products
CA2423806C (en)2000-09-292009-12-22Molecular Probes, Inc.Modified carbocyanine dyes and their conjugates
AU2002251841A1 (en)2001-01-302002-08-12Corixa CorporationCompositions and methods for the therapy and diagnosis of pancreatic cancer
WO2002070742A1 (en)2001-03-012002-09-12Epigenomics AgMethod for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes
CA2992643C (en)2002-03-132019-06-18Genomic Health, Inc.Gene expression profiling in biopsied tumor tissues
US20040029151A1 (en)2002-04-092004-02-12Affymetrix, Inc.Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer
US20050272052A1 (en)2002-04-092005-12-08Affymetrix, Inc.Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer
WO2003097878A1 (en)2002-05-212003-11-27Sysmex CorporationNucleic acid amplification primers for detecting cytokeratins and examination method with the use of the primers
AU2003279084A1 (en)2002-09-252004-04-19Genentech, Inc.Novel compositions and methods for the treatment of psoriasis
AU2003277016A1 (en)2002-09-262004-05-04Atomix, LlcRoto-dynamic fluidic system
US20050259483A1 (en)2002-09-302005-11-24Oncotherapy Science, Inc.Genes and polypeptides relating to prostate cancers
US6974874B2 (en)2002-10-312005-12-13Bayer Materialscience LlcReduction of monomer content and stabilization of polyaziridines
US20040109863A1 (en)2002-12-042004-06-10Peter EmtageMethods of therapy and diagnosis using targeting of cells that express Ly-9
DE10259703A1 (en)2002-12-192004-07-08Ivonex Gmbh separation process
EP2151507B1 (en)2002-12-202013-02-13Celera CorporationGenetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
US20070104688A1 (en)2003-02-132007-05-10City Of HopeSmall interfering RNA mediated transcriptional gene silencing in mammalian cells
WO2004076614A2 (en)2003-02-272004-09-10Bernd HinzmannHuman nucleic acid sequences obtained from prostatic carcinomas
US20070054271A1 (en)2003-03-202007-03-08Dana-Farber Cancer Institute, Inc.Gene expression in breast cancer
EP1631689A2 (en)2003-05-282006-03-08Genomic Health, Inc.Gene expression markers for predicting response to chemotherapy
KR20060031809A (en)2003-06-092006-04-13더 리젠츠 오브 더 유니버시티 오브 미시간 Compositions and methods for treating and diagnosing cancer
US20070048738A1 (en)2003-07-142007-03-01Mayo Foundation For Medical Education And ResearchMethods and compositions for diagnosis, staging and prognosis of prostate cancer
EP1656542A4 (en)2003-07-292008-09-03Bristol Myers Squibb CoBiomarkers of cyclin-dependent kinase modulation
EP1522594A3 (en)2003-10-062005-06-22Bayer HealthCare AGMethods and kits for investigating cancer
ITPD20030264A1 (en)2003-10-302005-04-30Xeptagen Spa HIGHLY SPECIFIC DIAGNOSIS METHOD FOR NEOPLASIA
CN1743849A (en)2004-09-032006-03-08上海透景生命科技有限公司Multi tumour tag parallel detecting method and kit
US20060057127A1 (en)2004-09-102006-03-16Pocheng LiuCytokine-expressing cellular vaccines for treatment of prostate cancer
US20060063214A1 (en)2004-09-172006-03-23Ozge AlperMethods and compositions for diagnosing neoplastic disease
US20060134663A1 (en)2004-11-032006-06-22Paul HarkinTranscriptome microarray technology and methods of using the same
WO2006091776A2 (en)*2005-02-252006-08-31The Brigham And Women's Hospital, Inc.Biomarkers for predicting prostate cancer progression
US8383357B2 (en)2005-03-162013-02-26OSI Pharmaceuticals, LLCBiological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
DE602006016085D1 (en)2005-03-162010-09-23Genentech Inc BIOLOGICAL MARKERS PREDICTIVE FOR THE APPLICATION OF CANCER TO INHIBITORS OF THE CINEMA OF THE RECEPTOR FOR EPIDERMAL GROWTH FACTOR
US7608413B1 (en)2005-03-252009-10-27Celera CorporationKidney disease targets and uses thereof
WO2006106823A1 (en)2005-03-312006-10-12Japan Science And Technology AgencyMethod for distinguishing mesenchymal stem cell using molecular marker and use thereof
WO2006124836A1 (en)2005-05-132006-11-23Duke UniversityGene expression signatures for oncogenic pathway deregulation
EP1883705A4 (en)2005-05-252009-02-25Expression Pathology IncMultiplex method for increased proteomic coverage from histopathologically processed biological samples using liquid tissue preparations
WO2006127861A2 (en)2005-05-252006-11-30Expression Pathology, Inc.Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations
WO2006135886A2 (en)2005-06-132006-12-21The Regents Of The University Of MichiganCompositions and methods for treating and diagnosing cancer
WO2006138275A2 (en)2005-06-132006-12-28The Regents Of The University Of MichiganCompositions and methods for treating and diagnosing cancer
EP1734118A1 (en)2005-06-152006-12-20Deutsches Krebsforschungszentrum Stiftung des öffentlichen RechtsIdentification of JAK/STAT pathway modulating genes by genome wide RNAi screening
US7842466B1 (en)2005-09-162010-11-30Celera CorporationColon disease targets and uses thereof
CA2625403A1 (en)2005-10-172007-04-26Institute For System BiologyTissue-and serum-derived glycoproteins and methods of their use
US20070220621A1 (en)2005-10-312007-09-20Clarke Michael FGenetic characterization and prognostic significance of cancer stem cells in cancer
WO2007119111A2 (en)2005-11-102007-10-25Aurelium Biopharma Inc.Tissue diagnostics for ovarian cancer
WO2007071947A1 (en)2005-12-192007-06-28University Of HullCancer screening test
US20070231822A1 (en)2006-02-282007-10-04Michael MitasMethods for the detection and treatment of cancer
JP4968577B2 (en)2006-04-112012-07-04エフ.ホフマン−ラ ロシュ アーゲー Rapid measurement method of cytokeratin 19 (CK19) mRNA, and primer and probe therefor
US20080003624A1 (en)2006-06-132008-01-03Sysmex CorporationCancer metastasis determination method
WO2008013989A2 (en)2006-07-272008-01-31Cell Genesys, Inc.Methods and compositions for identifying a cellular immune response against prostate cancer
EP2520935A3 (en)2006-08-092013-02-13Homestead Clinical CorporationOrgan-specific proteins and methods of their use
US8642349B1 (en)2006-08-112014-02-04H. Lee Moffitt Cancer Center And Research Institute, Inc.Artificial neural network proteomic tumor classification
US8748108B2 (en)2006-09-052014-06-10Abbvie Inc.Biomarkers for identifying patient classes
EP2064552B1 (en)2006-09-072011-08-31Universitätsklinikum Hamburg-EppendorfMethod for the detection of cancerous epithelial cells using released cytokeratins as markers for said cells
RU2473555C2 (en)2006-12-192013-01-27ДжинГоу, Инк.New method for functional analysis of body of experimental data and gene groups identified from said data
EP1972639A3 (en)2007-03-072008-12-03Cell Signaling Technology, Inc.Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
WO2008121307A2 (en)2007-03-282008-10-09Cell Genesys, Inc.Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer
US8492328B2 (en)2007-05-172013-07-23Bristol-Myers Squibb CompanyBiomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators
US20090221004A1 (en)2007-06-012009-09-03Anita Lim HongCaspase-cleavage anti-keratin antibodies for detection of apoptosis
EP2201134B1 (en)2007-09-192018-11-21The Research Foundation of State University of New YorkGene expression signatures in enriched tumor cell samples
EP2208066A2 (en)2007-10-032010-07-21OSI Pharmaceuticals, Inc.Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
US20090105167A1 (en)2007-10-192009-04-23Duke UniversityPredicting responsiveness to cancer therapeutics
JP5519523B2 (en)2007-12-042014-06-11アルニラム ファーマスーティカルズ インコーポレイテッド Carbohydrate conjugates as oligonucleotide delivery agents
EP2223115B1 (en)2007-12-102011-09-14Roche Diagnostics GmbHSeprase as a marker for cancer
CN102084000B (en)2008-02-012016-03-16总医院有限公司 Use of microbubbles in the diagnosis, prognosis and treatment of medical diseases and conditions
US8008032B2 (en)2008-02-252011-08-30Cellective Dx CorporationTagged ligands for enrichment of rare analytes from a mixed sample
JP2011528442A (en)2008-07-162011-11-17ディナ ファーバー キャンサー インスティチュート,インコーポレイテッド Prostate cancer related signs and PCDETERMINANT and methods of use thereof
WO2010011642A2 (en)2008-07-212010-01-28The Trustees Of The University Of PennsylvaniaMethods and compositions using splicing regulatory proteins involved in tumor suppression
EP2177615A1 (en)2008-10-102010-04-21Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.Method for a genome wide identification of expression regulatory sequences and use of genes and molecules derived thereof for the diagnosis and therapy of metabolic and/or tumorous diseases
US8312249B1 (en)2008-10-102012-11-13Apple Inc.Dynamic trampoline and structured code generation in a signed code environment
IT1391619B1 (en)2008-11-042012-01-11Silicon Biosystems Spa METHOD FOR THE IDENTIFICATION, SELECTION AND ANALYSIS OF TUMOR CELLS
JP5172020B2 (en)2008-11-122013-03-27エフ.ホフマン−ラ ロシュ アーゲー PACAP as a marker for cancer
WO2010065940A1 (en)2008-12-042010-06-10The Regents Of The University Of CaliforniaMaterials and methods for determining diagnosis and prognosis of prostate cancer
EP2380024B1 (en)2008-12-222014-06-11Roche Diagnostics GmbHArmet as a marker for cancer
WO2010099137A2 (en)2009-02-262010-09-02Osi Pharmaceuticals, Inc.In situ methods for monitoring the emt status of tumor cells in vivo
JP2012100536A (en)2009-03-022012-05-31Genescience Co LtdGenetic testing method for cancer by analysis of expression of cancer-relating gene utilizing monocyte contained in blood sample
US20110311443A1 (en)2009-03-062011-12-22Klaus Tschira Stiftung GgmbhPharmaceutical composition and method for identifying a cancerous and/or an inflammatory disease in a patient
EP2421900A1 (en)2009-04-242012-02-29Alper Biotech, LlcMonoclonal antibodies against pcbp-1 antigens, and uses therefor
US10815517B2 (en)2009-04-282020-10-27Roche Diagnostics Operations, Inc.Use of DPPIV/seprase as a marker for cancer
JP5892794B2 (en)2009-10-022016-03-23学校法人 久留米大学 Method for predicting therapeutic effect and / or prognosis after immunotherapy for cancer patients, and gene set and kit used for the method
EP2309262A1 (en)*2009-10-062011-04-13Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.Method for quantifying biomolecules
US9456558B2 (en)2009-10-292016-10-04King Kutter, Inc.Stump cutter
EP2335838B1 (en)2009-12-182012-09-26Deutsche Post AGSorting system and method using a portable device
US20130095503A1 (en)2010-01-052013-04-18University Of CincinnatiSerum spla2-iia as diagnosis marker for prostate and lung cancer
US20110177525A1 (en)2010-01-192011-07-21Predictive Biosciences, Inc.Antibodies and methods of diagnosing diseases
FR2957821B1 (en)2010-03-242014-08-29Inst Francais Du Petrole NEW AREA OF CATALYST REGENERATION DIVIDED IN SECTORS FOR REGENERATIVE CATALYTIC UNITS
US9469876B2 (en)2010-04-062016-10-18Caris Life Sciences Switzerland Holdings GmbhCirculating biomarkers for metastatic prostate cancer
US8664472B2 (en)2010-04-282014-03-04Sesaco CorporationPygmy sesame plants for mechanical harvesting
EP2390665A1 (en)2010-05-272011-11-30Atlas Antibodies ABProstate cancer biomarkers
US8557777B2 (en)2010-07-092013-10-15The Board Of Trustees Of The University Of IllinoisMethods for treating cancer using prostate specific antigen and tumor endothelial marker peptides
WO2012006634A2 (en)2010-07-092012-01-12The Board Of Trustees Of The University Of IllinioisProstate specific antigen (psa) peptide therapy
US9040464B2 (en)2010-08-162015-05-26Mount Sinai HosptialMarkers of the male urogenital tract
CA2808417A1 (en)2010-08-182012-02-23Caris Life Sciences Luxembourg Holdings, S.A.R.L.Circulating biomarkers for disease
WO2012031008A2 (en)2010-08-312012-03-08The General Hospital CorporationCancer-related biological materials in microvesicles
CN103476428B (en)2010-09-092016-10-26北京同为时代生物技术有限公司 Blood markers and their monoclonal antibodies for diagnosis of epithelial cancer
AU2011302152B2 (en)2010-09-152015-06-11Alnylam Pharmaceuticals, Inc.Modified iRNA agents
US9347953B2 (en)2010-12-062016-05-24Thd S.P.A.Method for the diagnosis of a carcinoma and uses thereof
AU2011349101A1 (en)2010-12-242013-05-02Map Diagnostics Pty LtdSelective reaction monitoring (SRM) derived protein profiles for cancer and other pathologic entities
ES2545515T3 (en)2011-01-282015-09-11F. Hoffmann-La Roche Ag Combinatorial biomarkers for clinical applications in the management of lung cancer patients
US9926601B2 (en)2011-02-242018-03-27Massachusetts Institute Of TechnologyAlternatively spliced mRNA isoforms as prognostic indicators for metastatic cancer
EA201391245A1 (en)2011-03-022014-05-30Берг Ллк INTERROGATIVE CELL ANALYSIS AND THEIR APPLICATION
KR101320633B1 (en)2011-05-252013-10-30엠앤디 (주)Method of providing information for diagnosis of cancer using quantitative realtime PCR and diagnostic kit comprising thereof
WO2012135397A2 (en)2011-03-292012-10-04Lisanti Michael PLactate-and ketones-induced gene signatures and use the same for diagnosing disease and predicting clinical outcome
CN103874706B (en)2011-04-282016-06-08贝勒医学院 Regenerated chimeric RNAs enriched in human prostate cancer as biomarkers
WO2012174256A2 (en)2011-06-172012-12-20The Regents Of The University Of MichiganDna methylation profiles in cancer
ES2571380T3 (en)2011-07-262016-05-25Univ Salamanca Method for the detection of cancerous infiltration in the central nervous system
CA2844671A1 (en)2011-08-082013-02-14Caris Life Sciences Luxembourg Holdings, S.A.R.L.Biomarker compositions and methods
WO2013039477A1 (en)2011-09-122013-03-21University Of South AlabamaNon-invasive methods of detecting target molecules
EP2823306A4 (en)2012-03-092015-11-11Caris Life Sciences Switzerland Holdings GmbhBiomarker compositions and methods
HK1208470A1 (en)2012-03-292016-03-04Biogen Ma Inc.Biomarkers for use in integrin therapy applications
US20130317083A1 (en)2012-05-042013-11-28Thomas Jefferson UniversityNon-coding transcripts for determination of cellular states
WO2013166676A1 (en)2012-05-092013-11-14华为技术有限公司Method and device for data transmission
WO2013173476A1 (en)2012-05-152013-11-21Predictive Biosciences, Inc.Detection of cancer
EA201492284A1 (en)2012-06-272015-11-30Берг Ллк APPLICATION OF MARKERS IN DIAGNOSTICS AND TREATMENT OF PROSTATE CANCER
TWI468519B (en)2012-09-052015-01-11Univ China Medical Methods of detecting squamous cell carcinoma in vitro
EP2895864B1 (en)2012-09-172021-03-10AIT Austrian Institute of Technology GmbHColon cancer diagnostic method and means
CN105008923B (en)*2013-01-222018-03-02新蛋白质组学公司 Platelet Biomarkers in Cancer Diagnostics
US9201061B2 (en)2013-02-262015-12-01Industry-University Cooperation Foundation Hanyang UniversityKRT19 stabilizing HER2 and use thereof
WO2014160499A2 (en)2013-03-132014-10-02Creatics LlcMethods and compositions for detecting pancreatic cancer
US20140296096A1 (en)2013-03-272014-10-02Oslo Universitetssykehus HfProstate cancer markers and uses thereof
SE538211C2 (en)2013-04-052016-04-05Idl Biotech Ab Method for detecting cytokeratin 8, 18 and / or 19 and / or soluble fragments thereof
US20150079590A1 (en)2013-09-182015-03-19Beth Israel Deaconess Medical Center, Inc.Characterization and analysis of the composition and dynamics of the mammalian riboproteome
EP3047270A4 (en)2013-09-202017-07-19Astute Medical, Inc.Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain

Also Published As

Publication numberPublication date
EP4242329A2 (en)2023-09-13
US10539566B2 (en)2020-01-21
IL252766B (en)2021-07-29
CN107428821B (en)2022-06-24
AU2015360694B2 (en)2021-10-14
US20250123283A1 (en)2025-04-17
SG10202012249YA (en)2021-01-28
EP3230314B1 (en)2023-05-03
US20160258958A1 (en)2016-09-08
EP3230314A1 (en)2017-10-18
WO2016094425A1 (en)2016-06-16
US20200333344A1 (en)2020-10-22
EP3230314A4 (en)2018-06-06
NZ732512A (en)2024-11-29
AU2015360694A1 (en)2017-06-29
KR102657306B1 (en)2024-04-12
EP4242329A3 (en)2023-10-25
CA2970143A1 (en)2016-06-16
CN107428821A (en)2017-12-01
IL252766A0 (en)2017-08-31
JP6759229B2 (en)2020-09-23
JP2018506045A (en)2018-03-01
KR20170092671A (en)2017-08-11

Similar Documents

PublicationPublication DateTitle
IL252766B (en)Use of markers including filamin a in the diagnosis and treatment of prostate cancer
ZA201607415B (en)Antibody-drug-conjugate and its use for the treatment of cancer
GB201403093D0 (en)Therapeutic compounds and their use
IL248455A0 (en)Igf-1r antibody-drug-conjugate and its use for the treatment of cancer
IL276733A (en)Use of eribulin in the treatment of cancer
IL251630A0 (en)Combination therapy for use in cancer therapy
SG11201701035SA (en)Cancer diagnosis and therapy
IL236482A0 (en)Use of markers in the diagnosis and treatment of prostate cancer
IL249741B (en)Identification of cancer stem cells markers and use of same for diagnosis and treatment
GB201409363D0 (en)Skin cancer treatment
PL3258931T3 (en)Use of cabazitaxel in the treatment of prostate cancer
IL269121A (en)Usl-311 for use in the treatment of cancer
IL273054B1 (en)Abx196 for use in the treatment of bladder cancer
IL251825B1 (en)Cancer and skin lesion treatment
GB201612794D0 (en)Therapeutic use of diethanololeamide in prostate cancer treatment
GB201411111D0 (en)bis-Pyridazine compounds and their use in treating cancer
GB201410387D0 (en)Compounds and their therapeutic use
GB201409978D0 (en)Novel compounds and their use in therapy
GB201403496D0 (en)Compounds and their therapeutic use

[8]ページ先頭

©2009-2025 Movatter.jp